The North American Nuclear Medicine/Radiopharmaceuticals Market is expected to grow from USD 2.33 billion in 2019 to USD 3.14 billion by 2026 at a CAGR of 4% from 2020 to 2026.
Nuclear medicine is a field that employs radioactive materials to diagnose and treat diseases. The radiopharmaceuticals used in radioactive mixtures and nuclear medicine are ordered to the patient and analyzed via particular imaging devices for therapy and diagnosis. Factors such as an increase in cases of cancer and other target conditions targeted cancer treatment with the support of alpha radioimmunotherapy, initiatives to bridge the demand-supply gap of Mo-99, convenience of treatment, implementation of clear imaging procedure, and technological advancements will act as major driving factors in the growth of the market. Application of radiopharmaceuticals in neurology and favorable government policies in developing regions will act as an opportunity for the market players in the nuclear medicine/ radiopharmaceuticals market. Nonetheless, the short half-life of radiopharmaceuticals, shortage in supply, difficulties in logistics, a dearth of skilled personnel, and lack of awareness in low-income nations will restrict the growth of nuclear medicine/ radiopharmaceuticals market.
The market is segregated on the basis of Application as Diagnostic Applications Based on Procedural Volume Assessment the market is segmented in Therapeutic Procedures and Diagnostic Procedures. Based on Type the market is segmented in Brachytherapy Isotopes, Therapeutic Nuclear Medicine, and Diagnostic Nuclear Medicine.
Competitive Rivalry
Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications, NTP Radioisotopes Soc, LTD, Cardinal Health, Curium, GE Healthcare, Lantheus Medical Imaging, Inc, Bayer AG, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The North American Nuclear Medicine/Radiopharmaceuticals market has been segmented as below:
By Application
By Procedural Volume Assessment
By Type
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications, NTP Radioisotopes Soc, LTD, Cardinal Health, Curium, GE Healthcare, Lantheus Medical Imaging, Inc, Bayer AG, and others.
Why to Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Diagnostic Applications
5.2.1 Market Overview
5.2.2 Market Size and Forecast
6.1 Introduction
6.2 Therapeutic Procedures
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Diagnostic Procedures
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7.1 Introduction
7.2 Brachytherapy Isotopes
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Therapeutic Nuclear Medicine
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Diagnostic Nuclear Medicine
7.4.1 Market Overview
7.4.2 Market Size and Forecast
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10.1 Bracco Imaging S.P.A
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Eczacibasi-Monrol Nuclear Products
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Nordion, Inc.
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Advanced Accelerator Applications
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 NTP Radioisotopes Soc, LTD
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Cardinal Health
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Curium
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 GE Healthcare
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Lantheus Medical Imaging, Inc
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Bayer AG
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The North American Nuclear Medicine/Radiopharmaceuticals market has been segmented as below:
By Application
By Procedural Volume Assessment
By Type
By Company